Abstract
BackgroundThe Evidence that NIV is an effective treatment for patients with COPD who present in Acute Type 2 Respiratory Failure is well documented. Yet despite NIV being considered the gold...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
